Cresilon Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 92

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $48.7M

  • Investors
  • 6

Cresilon General Information

Description

Manufacturer of a plant-based hemostatic gel designed for the immediate cessation of traumatic bleeding. The company's platform utilizes a proprietary blend of biopolymers that instantaneously form a mechanical barrier to seal wounds without the need for manual pressure, enabling healthcare providers and emergency responders to rapidly stabilize patients and improve survival outcomes during critical surgical or field trauma situations.

Contact Information

Website
www.cresilon.com
Formerly Known As
Suneris
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 86 34th Street
  • Suite D603/D604, Brooklyn
  • New York, NY 11232
  • United States
+1 (347)
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Therapeutic Devices
Other Commercial Products
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 86 34th Street
  • Suite D603/D604, Brooklyn
  • New York, NY 11232
  • United States
+1 (347)

Cresilon Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cresilon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series A) 23-Jun-2026 $48.7M Completed Generating Revenue
12. Debt - General Completed Generating Revenue
11. Later Stage VC (Series A) 18-Apr-2024 Completed Generating Revenue
10. Later Stage VC (Series A) 23-Sep-2022 Completed Generating Revenue
9. Later Stage VC (Series A3) 12-Feb-2021 Completed Generating Revenue
8. Debt - PPP 27-Apr-2020 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
5. Accelerator/Incubator 01-Mar-2018 $22.3M Completed Generating Revenue
4. Later Stage VC (Series A) 08-Feb-2018 $13.3M $22.3M Completed Generating Revenue
To view Cresilon’s complete valuation and funding history, request access »

Cresilon Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-5
Series A-4
Series A-3 Shadow
Series A-3
Series A-2
Series A-1 3,721,498 $0.001000 $1.57 $1.57 1x $1.57 2.23%
Series A 8,879,635 $0.001000 $1 $1 1x $1 5.33%
To view Cresilon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cresilon Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Cresilon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023024742-A Highly useful hemostatic adhesive polymer scaffolds Pending 04-Mar-2020
US-20190282760-A1 Delivery device for hemostatic compositions Inactive 13-Mar-2018
US-20230166041-A1 Delivery device for hemostatic compositions Inactive 13-Mar-2018
US-D909570-S1 Delivery device for hemostatic compositions Active 13-Mar-2018
WO-2019178221-A1 Delivery device for hemostatic compositions Inactive 13-Mar-2018 A61M5/30
To view Cresilon’s complete patent history, request access »

Cresilon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cresilon Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Innovating Capital Venture Capital Minority
Paulson Investment Company Investment Bank Minority
Valued Ventures Venture Capital Minority
Entrepreneurship Lab Bio & Health Tech NYC Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Cresilon FAQs

  • When was Cresilon founded?

    Cresilon was founded in 2010.

  • Where is Cresilon headquartered?

    Cresilon is headquartered in New York, NY.

  • What is the size of Cresilon?

    Cresilon has 92 total employees.

  • What industry is Cresilon in?

    Cresilon’s primary industry is Medical Supplies.

  • Is Cresilon a private or public company?

    Cresilon is a Private company.

  • What is Cresilon’s current revenue?

    The current revenue for Cresilon is .

  • How much funding has Cresilon raised over time?

    Cresilon has raised $160M.

  • Who are Cresilon’s investors?

    , Innovating Capital, Paulson Investment Company, Valued Ventures, and Entrepreneurship Lab Bio & Health Tech NYC are 5 of 6 investors who have invested in Cresilon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process